Cargando…

COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease

INTRODUCTION: Chronic kidney disease (CKD) patients infected with COVID-19 are at risk of serious complications such as hospitalization and death. The prognosis and lethality of COVID-19 infection in patients with established kidney disease has not been widely studied. METHODS: Data included patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Román, Juan León, García-Carro, Clara, Agraz, Irene, Toapanta, Nestor, Vergara, Ander, Gabaldón, Alejandra, Torres, Irina, Bury, Roxana, Baldallo, Cinthia, Serón, Daniel, Soler, María José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247815/ https://www.ncbi.nlm.nih.gov/pubmed/34098555 http://dx.doi.org/10.1159/000515714

Ejemplares similares

COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?
por: León-Román, Juan, et al.
Publicado: (2022)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Correction to: Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
Publicado: (2022)

Safety of Obtaining an Extra Biobank Kidney Biopsy Core
por: Bermejo, Sheila, et al.
Publicado: (2022)

Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers
por: Jacobs-Cachá, Conxita, et al.
Publicado: (2020)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Infección por COVID-19 en una paciente con síndrome urticarial hipocomplementémico y vasculitis ANCA MPO en hemodiálisis tratada con omalizumab
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
por: Oleas, Diana, et al.
Publicado: (2020)

Glomeruloesclerosis focal y segmentaria asociada a infección por COVID-19
por: LeónRomán, Juan, et al.
Publicado: (2021)

Focal and segmental glomerulosclerosis associated with COVID-19 infection()
por: Román, Juan León, et al.
Publicado: (2021)

The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes
por: García-Carro, Clara, et al.
Publicado: (2019)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?
por: Agraz-Pamplona, Irene, et al.
Publicado: (2020)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

CKD Prevalence in the Military Health System: Coded Versus Uncoded CKD
por: Norton, Jenna M., et al.
Publicado: (2021)

Early Ultrastructural Changes in Biopsies From Patients With Symptomatic CKD of Uncertain Etiology
por: Daniel, Christoph, et al.
Publicado: (2022)

Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience
por: Zamora, Jorge Iván, et al.
Publicado: (2023)

Memorandum 553
por: Gotta, D
Publicado: (1995)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

The Role of Inflammation in CKD
por: Kadatane, Saurav Prashant, et al.
Publicado: (2023)

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
por: Argilés, Àngel, et al.
Publicado: (2013)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes
por: Mullins, C. Daniel, et al.
Publicado: (2022)

The Higher the CKD Stage, the Higher the Psychological Stress in Patients with CKD during COVID-19 Pandemic
por: Lee, Kyung-Mi, et al.
Publicado: (2022)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Strategies for Phosphate Control in Patients With CKD
por: Barreto, Fellype Carvalho, et al.
Publicado: (2019)

Abdominal aortic calcification in patients with CKD
por: Peeters, Mieke J., et al.
Publicado: (2016)

The Influence of Inflammation on Anemia in CKD Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2020)

Bone Fragility Fractures in CKD Patients
por: Pimentel, Ana, et al.
Publicado: (2020)

Energy Requirement for Elderly CKD Patients
por: D’Alessandro, Claudia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qi3ud217brc6a524h5ehbm770g